- Home
- SLVM
SLVM
Sylvamo Corporation
as 07-03-2025 4:00pm EST
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.
| Founded: | 1898 | Country: | United States |
| Employees: | N/A | City: | MEMPHIS |
| Market Cap: | 2.4B | IPO Year: | N/A |
| Target Price: | $85.67 | AVG Volume (30 days): | 280.2K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 6.82 | EPS Growth: | 45.44 |
| 52 Week Low/High: | $49.93 - $98.02 | Next Earning Date: | 08-08-2025 |
| Revenue: | $3,689,000,000 | Revenue Growth: | 0.11% |
| Revenue Growth (this year): | -7.71% | Revenue Growth (next year): | 0.14% |
Stock Insider Trading Activity of Sylvamo Corporation (SLVM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Gottung Lizanne C | SLVM | Director | Jun 11 '25 | Sell | $52.60 | 2,000 | $105,200.00 | 11,829 |
Latest Sylvamo Corporation News
SLVM Breaking Stock News: Dive into SLVM Ticker-Specific Updates for Smart Investing
Argus Research
9 days ago
SLVM: Raising target price to $54.00
Argus Research
23 days ago
SLVM: What does Argus have to say about SLVM?
ACCESS Newswire
24 days ago
Sidoti Events, LLC's Virtual June Small-Cap Conference
Yahoo Finance Video
a month ago
Will Tesla have to play catch up to Waymo's robotaxis?
Yahoo Finance
a month ago
Why Scott Bessent wants to make it easier for banks to own Treasurys
GlobeNewswire
a month ago
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
GlobeNewswire
a month ago
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
CNW Group
a month ago
Statement by Minister Guilbeault on Portuguese Heritage Month
Compare SLVM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SLVM Sylvamo Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.